Evidence-Based Medicine Guidelines
Anti-Saccharomyces cerevisiae (ASCA) and perinuclear antineutrophil cytoplasmic antibodies (pANCA) in the diagnosis of Crohn's disease and ulcerative colitis
Anti-Saccharomyces cerevisiae (ASCA) and perinuclear antineutrophil cytoplasmic antibodies (pANCA) in the diagnosis of Crohn's disease and ulcerative colitis is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Anti-Saccharomyces Cerevisiae (ASCA) and Perinuclear Antineutrophil Cytoplasmic Antibodies (pANCA) in the Diagnosis of Crohn's Disease and Ulcerative Colitis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450864/all/Anti_Saccharomyces_cerevisiae__ASCA__and_perinuclear_antineutrophil_cytoplasmic_antibodies__pANCA__in_the_diagnosis_of_Crohn's_disease_and_ulcerative_colitis.
Anti-Saccharomyces cerevisiae (ASCA) and perinuclear antineutrophil cytoplasmic antibodies (pANCA) in the diagnosis of Crohn's disease and ulcerative colitis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450864/all/Anti_Saccharomyces_cerevisiae__ASCA__and_perinuclear_antineutrophil_cytoplasmic_antibodies__pANCA__in_the_diagnosis_of_Crohn's_disease_and_ulcerative_colitis. Accessed November 30, 2020.
Anti-Saccharomyces cerevisiae (ASCA) and perinuclear antineutrophil cytoplasmic antibodies (pANCA) in the diagnosis of Crohn's disease and ulcerative colitis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. Retrieved November 30, 2020, from https://evidence.unboundmedicine.com/evidence/view/EBMG/450864/all/Anti_Saccharomyces_cerevisiae__ASCA__and_perinuclear_antineutrophil_cytoplasmic_antibodies__pANCA__in_the_diagnosis_of_Crohn's_disease_and_ulcerative_colitis
Anti-Saccharomyces Cerevisiae (ASCA) and Perinuclear Antineutrophil Cytoplasmic Antibodies (pANCA) in the Diagnosis of Crohn's Disease and Ulcerative Colitis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2020 November 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450864/all/Anti_Saccharomyces_cerevisiae__ASCA__and_perinuclear_antineutrophil_cytoplasmic_antibodies__pANCA__in_the_diagnosis_of_Crohn's_disease_and_ulcerative_colitis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti-Saccharomyces cerevisiae (ASCA) and perinuclear antineutrophil cytoplasmic antibodies (pANCA) in the diagnosis of Crohn's disease and ulcerative colitis
ID - 450864
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450864/all/Anti_Saccharomyces_cerevisiae__ASCA__and_perinuclear_antineutrophil_cytoplasmic_antibodies__pANCA__in_the_diagnosis_of_Crohn's_disease_and_ulcerative_colitis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
